Active	Status	Sponsor type	Region	Phase	Filter
1 Active 5 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
patidegib topical (IPI-926 topical) / Bridge Biotherap, LEO Pharma
NCT06050122: Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults with Gorlin Syndrome	Recruiting	3	140	Europe, US	Patidegib Topical Gel, Patidegib, IPI-926, Saridegib, SGT-610, Patidegib Topical Gel with no active patidegib, Vehicle Gel, Placebo	Sol-Gel Technologies, Ltd., Premier Research Group plc	Gorlin Syndrome	12/25	12/25